Mehran Afshar
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.
Journal: The oncologist
Published: December 16, 2025
Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.
Journal: The oncologist
Published: December 16, 2025
Six-Month Survivorship Prediction in Spinal Metastatic Patients by Oncologists Shows Reliable Prognostication.
Journal: Global spine journal
Published: November 27, 2023
A new prognostic model for predicting 30-day mortality in acute oncology patients.
Journal: Expert review of anticancer therapy
Published: July 30, 2021
Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis.
Journal: BJU international
Published: November 29, 2020
New Approaches to Cancer Care in a COVID-19 World-The Role of Health and Social Protection Policies.
New Approaches to Cancer Care in a COVID-19 World-The Role of Health and Social Protection Policies.
Journal: JAMA oncology
Published: November 25, 2020
Nocardia farcinica masquerading as intracerebral metastases in advanced metastatic prostatic cancer.
Nocardia farcinica masquerading as intracerebral metastases in advanced metastatic prostatic cancer.
Journal: BMJ case reports
Published: September 09, 2020
Red cell differential width (RDW) as a predictor of survival outcomes with palliative and adjuvant chemotherapy for metastatic penile cancer.
Journal: International urology and nephrology
Published: June 18, 2020
Robotic-assisted partial nephrectomy (RAPN) and standardization of outcome reporting: a prospective, observational study on reaching the "Trifecta and Pentafecta".
Journal: Journal of robotic surgery
Published: May 05, 2020
Are health-care policies restricting further progress in cancer survival outcomes?
Journal: The Lancet. Oncology
Published: November 05, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?
Journal: Expert review of anticancer therapy
Published: April 18, 2019
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015.
Journal: European urology oncology
Published: October 04, 2018
Last Updated: 09/26/2026